TrialAntimicrobial agents and chemotherapy2025

Cytomegalovirus prophylaxis with letermovir in pediatric (birth to <18 years of age) hematopoietic cell transplant recipients: pharmacokinetics, efficacy, and safety results of a Phase 2b study.

Andreas H Groll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.